21 Feb 2020 Safety Assessment of Cosmetic Products

18 Feb 2020

Regulatory Day 2020

6 Feb 2020

Estamos a recrutar - Medical Writer

A OWLpharma tem em aberto uma vaga para Medical Writer no Departamento Médico-Científico, em Coimbra.

21 Jan 2020

Nitrosamines – Risk evaluation

At the end of September EMA began a review under the Article 5(3) of Regulation (EC) No 726/2004 to provide guidance for MAHs on how to avoid nitrosamines in human medicines.

21 Jan 2020

GMP for Medicinal Cannabis – 29th of January

André Luz, the Director of Quality Assurance at Owlpharma, will be presenting a “GMP for Medicinal Cannabis” training on January 29th in collaboration with Formiventos.